Phase
Condition
Diabetes Mellitus, Type 2
Diabetic Vitreous Hemorrhage
Diabetic Foot Ulcers
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Type 2 diabetes
Treated with OADs for more than or equal to 3 months
HbA1c greater than or equal to 8.0% and less than or equal to 11.0%
Body Mass Index (BMI) less than or equal to 40.0 kg/m2
Exclusion
Exclusion Criteria:
Recurrent major hypoglycaemia
Current smoking or smoking within the last 6 months
Impaired hepatic or renal function
Cardiac problems
Uncontrolled hypertension
Proliferative retinopathy or maculopathy
Study Design
Study Description
Connect with a study center
Novo Nordisk Investigational Site
Buenos Aires, C1425AGC
ArgentinaSite Not Available
Novo Nordisk Investigational Site
Ciudad de Mendoza, 5500
ArgentinaSite Not Available
Novo Nordisk Investigational Site
Mar del Plata, B7600FZN
ArgentinaSite Not Available
Novo Nordisk Investigational Site
Ebreichsdorf, 2483
AustriaSite Not Available
Novo Nordisk Investigational Site
Kittsee, A 2421
AustriaSite Not Available
Novo Nordisk Investigational Site
Salzburg, 5020
AustriaSite Not Available
empty
Vienna,
AustriaSite Not Available
Novo Nordisk Investigational Site
Wien, A 1160
AustriaSite Not Available
Novo Nordisk Investigational Site
Arlon, 6700
BelgiumSite Not Available
Novo Nordisk Investigational Site
Bonheiden, 2820
BelgiumSite Not Available
Novo Nordisk Investigational Site
Borsbeek, 2150
BelgiumSite Not Available
Novo Nordisk Investigational Site
Gent, 9000
BelgiumSite Not Available
Novo Nordisk Investigational Site
Huy, 4500
BelgiumSite Not Available
Novo Nordisk Investigational Site
Leuven, 3000
BelgiumSite Not Available
Novo Nordisk Investigational Site
Sofia, 1431
BulgariaSite Not Available
Novo Nordisk Investigational Site
Edmonton, Alberta T5J 3N4
CanadaSite Not Available
Novo Nordisk Investigational Site
Winnipeg, Manitoba R3E 3P4
CanadaSite Not Available
Novo Nordisk Investigational Site
Halifax, Nova Scotia B3H 2Y9
CanadaSite Not Available
Novo Nordisk Investigational Site
Hamilton, Ontario L8L 2X2
CanadaSite Not Available
Novo Nordisk Investigational Site
Smiths Falls, Ontario K7A 4W8
CanadaSite Not Available
Novo Nordisk Investigational Site
Laval, Quebec H7T 2P5
CanadaSite Not Available
Novo Nordisk Investigational Site
Sherbrooke, Quebec J1H 5N4
CanadaSite Not Available
Novo Nordisk Investigational Site
Mississauga, L5M 2V8
CanadaSite Not Available
Novo Nordisk Investigational Site
Oshawa, L1J 2K1
CanadaSite Not Available
Novo Nordisk Investigational Site
Saskatoon, S7N 0W8
CanadaSite Not Available
Novo Nordisk Investigational Site
Trois-Rivieres, G8T 7A1
CanadaSite Not Available
Novo Nordisk Investigational Site
Corbeil Essonnes, 91106
FranceSite Not Available
Novo Nordisk Investigational Site
NEVERS cedex, 58033
FranceSite Not Available
Novo Nordisk Investigational Site
Nantes, 44093
FranceSite Not Available
Novo Nordisk Investigational Site
Narbonne, 11108
FranceSite Not Available
Novo Nordisk Investigational Site
Paris, 75877
FranceSite Not Available
Novo Nordisk Investigational Site
Roubaix, 59100
FranceSite Not Available
Novo Nordisk Investigational Site
Indore, Madhya Pradesh 452010
IndiaSite Not Available
Novo Nordisk Investigational Site
Bangalore, 560041
IndiaSite Not Available
Novo Nordisk Investigational Site
Coimbatore, 641002
IndiaSite Not Available
Novo Nordisk Investigational Site
Hyderabad, 600034
IndiaSite Not Available
Novo Nordisk Investigational Site
Thriruvananthapuram, 695 032
IndiaSite Not Available
Novo Nordisk Investigational Site
Beer Sheva, 84101
IsraelSite Not Available
Novo Nordisk Investigational Site
Holon, 58100
IsraelSite Not Available
Novo Nordisk Investigational Site
Jerusalem, 91120
IsraelSite Not Available
Novo Nordisk Investigational Site
Mexico City, México, D.F. 14000
MexicoSite Not Available
Novo Nordisk Investigational Site
Monterrey, Nuevo León 64460
MexicoSite Not Available
Novo Nordisk Investigational Site
Guadalajara, 44600
MexicoSite Not Available
Novo Nordisk Investigational Site
Mexico city, 11650
MexicoSite Not Available
Novo Nordisk Investigational Site
Gdansk, 80-858
PolandSite Not Available
Novo Nordisk Investigational Site
Lodz, 90-030
PolandSite Not Available
Novo Nordisk Investigational Site
Lublin, 20-044
PolandSite Not Available
Novo Nordisk Investigational Site
Mazowieckie, 09-400
PolandSite Not Available
Novo Nordisk Investigational Site
Rawa Mazowiecka, 96-200
PolandSite Not Available
Novo Nordisk Investigational Site
Warszawa, 02-097
PolandSite Not Available
Novo Nordisk Investigational Site
Zabrze, 41-800
PolandSite Not Available
Novo Nordisk Investigational Site
Istanbul, 34718
TurkeySite Not Available
Novo Nordisk Investigational Site
Konya, 42001
TurkeySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.